DE2515115A1 - 3 beta-hydroxy-2-(substituierte 1-alkenyl)-5-oxocyclopentan-1-heptansaeuren - Google Patents

3 beta-hydroxy-2-(substituierte 1-alkenyl)-5-oxocyclopentan-1-heptansaeuren

Info

Publication number
DE2515115A1
DE2515115A1 DE19752515115 DE2515115A DE2515115A1 DE 2515115 A1 DE2515115 A1 DE 2515115A1 DE 19752515115 DE19752515115 DE 19752515115 DE 2515115 A DE2515115 A DE 2515115A DE 2515115 A1 DE2515115 A1 DE 2515115A1
Authority
DE
Germany
Prior art keywords
hydroxy
carbon atoms
parts
alkyl radical
heptanoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752515115
Other languages
German (de)
English (en)
Inventor
Clifford Russell Dorn
Masateru Miyano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of DE2515115A1 publication Critical patent/DE2515115A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DE19752515115 1974-04-08 1975-04-07 3 beta-hydroxy-2-(substituierte 1-alkenyl)-5-oxocyclopentan-1-heptansaeuren Withdrawn DE2515115A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45879974A 1974-04-08 1974-04-08

Publications (1)

Publication Number Publication Date
DE2515115A1 true DE2515115A1 (de) 1975-10-16

Family

ID=23822127

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752515115 Withdrawn DE2515115A1 (de) 1974-04-08 1975-04-07 3 beta-hydroxy-2-(substituierte 1-alkenyl)-5-oxocyclopentan-1-heptansaeuren

Country Status (14)

Country Link
JP (1) JPS5835183B2 (xx)
AT (1) AT348154B (xx)
BE (1) BE827694A (xx)
CA (1) CA1071625A (xx)
CH (1) CH609971A5 (xx)
DE (1) DE2515115A1 (xx)
DK (1) DK147075A (xx)
ES (1) ES436362A1 (xx)
FR (1) FR2266500B1 (xx)
GB (1) GB1496716A (xx)
IE (1) IE41470B1 (xx)
NL (1) NL7504104A (xx)
SE (1) SE420998B (xx)
ZA (1) ZA752183B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60102774U (ja) * 1983-12-14 1985-07-13 ソニー株式会社 フロツピ−デイスクカセツト
JPS60106272U (ja) * 1983-12-24 1985-07-19 ソニー株式会社 フロツピ−デイスクカセツト
JPS60106271U (ja) * 1983-12-24 1985-07-19 ソニー株式会社 フロツピ−デイスクカセツト
JPS60140266U (ja) * 1984-02-25 1985-09-17 ソニー株式会社 磁気デイスク装置
JPS6121075U (ja) * 1984-07-07 1986-02-06 ティーディーケイ株式会社 デイスクカ−トリツジ

Also Published As

Publication number Publication date
CA1071625A (en) 1980-02-12
SE7503928L (sv) 1975-10-09
BE827694A (fr) 1975-10-08
ATA261475A (de) 1978-06-15
DK147075A (xx) 1975-10-09
NL7504104A (nl) 1975-10-10
JPS5835183B2 (ja) 1983-08-01
FR2266500A1 (xx) 1975-10-31
ES436362A1 (es) 1977-01-01
ZA752183B (en) 1976-06-30
IE41470B1 (en) 1980-01-16
AT348154B (de) 1979-02-12
AU7990675A (en) 1976-10-14
JPS50137960A (xx) 1975-11-01
IE41470L (en) 1975-10-08
GB1496716A (en) 1977-12-30
CH609971A5 (en) 1979-03-30
SE420998B (sv) 1981-11-16
FR2266500B1 (xx) 1978-07-28

Similar Documents

Publication Publication Date Title
DE2513212C2 (de) Methyl-7-[3-hydroxy-2-(4-hydroxy-4-methyl-trans-1-octenyl)-5-oxocyclopentan]-1-heptanoat, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Präparate
DE2652256C2 (de) Polyprenylalkohole und diese enthaltende pharmazeutische Zusammensetzungen
EP0534423A1 (de) 14-Hydroxy-N-(2-methoxyethyl)-7,8-dihydromorphin und - norisomorphin, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE2242239A1 (de) Neue 2-descarboxy-2- eckige klammer auf tetrazol-5-yl eckige klammer zu prostaglandine, verfahren zu ihrer herstellung sowie zwischenprodukte
DE2710242A1 (de) 5-eckige klammer auf 1,1-diphenyl- 3-(5- oder 6-hydroxy-2-azabicyclo eckige klammer auf 2,2,2 eckige klammer zu oct-2-yl)propyl eckige klammer zu -2- alkyl-1,3,4-oxadiazole und verwandte verbindungen
DE2714129A1 (de) Prostaglandinderivate, verfahren zu deren herstellung und deren verwendung
DE2831761C2 (de) 2,3- und 2,3,6-substituierte-4-Pyrone und deren Verwendung
DE2515115A1 (de) 3 beta-hydroxy-2-(substituierte 1-alkenyl)-5-oxocyclopentan-1-heptansaeuren
CH631700A5 (de) Verfahren zur herstellung von neuen substituierten diphenylsulfiden.
DE2234709A1 (de) Prostanoesaeurederivate
DE3113149C2 (xx)
DE2723213C2 (de) Polyprenylcarbonsäure-Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CH629493A5 (en) Processes for preparing novel prostaglandin derivatives
DE2346706A1 (de) Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung
CH617186A5 (xx)
DE2647969A1 (de) Cyclische amide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2443746A1 (de) 4',5-dihydro-7alpha-alkoxycarbonylspiro eckige klammer auf androst-4-en17,2'(3'h)-furan eckige klammer zu -3-one und entsprechende delta hoch 1,4-verbindungen
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
CH623570A5 (xx)
DE2825440C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE2621576A1 (de) 3,5-bisoxydierte-2-(omega-halogen- 3-oxydierte-1-alkenyl)-cyclopentan-1- oenanthsaeuren und deren derivate, die herstellung dieser verbindungen sowie diese verbindungen enthaltende praeparate
CH622020A5 (xx)
CH633551A5 (de) Verfahren zur herstellung von neuen thromboxan-analoga.
DE2355042A1 (de) Neue prostaglandinanaloge und verfahren zu deren herstellung
DE2513371C2 (de) 9,11,15-Trihydroxy-13-thia-5-prostensäure-Derivate und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal